Global Nuclear Medicine Diagnostics Market (SPECT and PET ) - Analysis and Forecasts (2014-2019)

LONDON, Oct. 1, 2015 /PRNewswire/ -- The nuclear medicine market report consists of a detailed account of the definition of Radiopharmaceuticals; Market dynamics- drivers, restraints, opportunities and threats; the market is segmented by Diagnostic technologies and applications. It also gives a detailed account of the various players in the market and the competitive landscape.

The global nuclear medicine diagnostic (PET and SPECT) market is expected to grow from an estimated $ 8.77 billion in 2014 to $ 15.51 billion in 2019, at an estimated compound annual growth rate (CAGR) of 12.08 %.

Major factors for the growth of the market are increasing use of SPECT and PET in medical diagnostics, increasing awareness of people about radiopharmaceuticals, and ready availability of radiopharmaceuticals.It has novel applications in treatment and diagnosis of diseases such as Alzheimer's and the continually expanding oncology segment. However, some of the major constraints for the market are shorter half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues.

Till now, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to flip upside down because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners will account for a potentially large market size in the coming years.

The emerging market trend will be a fusion of nuclear imaging with different diagnostic imaging products such as PET/CT, SPECT/CT, and MRI/PET. This provides full gamut of imaging scans through the same unit and at the same time. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures.

Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging. While, SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. North America has 5729 PET procedures while the number of PET procedures in Asia-Pacific region is 369636 owing to the increased demand of nuclear medicine diagnostic procedures in developing nations.

Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and others) and PET (Fluorine-18, Rubidium-82 (RB-82) and others). By application market is segmented into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET(oncology, cardiology, neurology and others).By geography market is segmented into North America, Europe and Asia-Pacific etc. North America accounts for the highest share of the global nuclear medicine diagnostic market; followed by Europe and Asia-Pacific. Asian countries are expected to show a growing trend in diagnostic sector because of increasing diagnostic procedure demand and rise in medical device industry.

Major players in the market are CardiArcLtd., Digirad Corporation, Gamma Medica Inc., GE Healthcare, Hologic Inc. etc. Mergers and acquisitions of small and medium sized manufacturers to enter in overseas market is another strategy adopted by multinational players.



What the report offers

1)Market Definition Global nuclear medicine diagnostic (SPECT and PET) market along with identification of key drivers and restraints for the market.

2)Market analysis for the Global nuclear medicine diagnostic (SPECT and PET), with region specific assessments and competition analysis on a global and regional scale.

3)Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4)Extensively researched competitive landscape section with profiles of major companies along with their share of markets.

5) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Reasons for Buying this Report

1)For gaining an exhaustive understanding of the worldwide market for Global nuclear medicine diagnostic (SPECT and PET) . Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.

2)An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.

3)Wide-ranging information provided about the leading market players and the major strategies adopted by them.

Download the full report: https://www.reportbuyer.com/product/3281739/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com